Managing Partner
Current- New Class of Trade in pharmaceutical industry (MBM)- Significant value beyond what PBM's and GPO's are able to provide.- Used by some of America's most recognizable organizations / companies / institutions.- Ultimate in transparency & integrity.- Eliminate hidden spreads and validate that you are receiving actual or true net costs.- Significant reductions in PMPM costs vs. what PBM's can provide (Approx. $50 or less, much less if non-profit or 340b).- Payers and plan sponsors receive true net costs and are ONLY billed what the pharmacy was paid- Patent-pending acquisition cost method that doesn't rely on fictitious MAC lists or antiquated reimbursement methods such as AWP, WAC, MAC. This combined with a professional fee puts emphasis where it should be, out of the PBM and back into the pharmacy to offer the best point of care for members. This also provides payers with the assurance that what is billed to them is what was paid to the pharmacy.- Fully auditable, fully customizable, and no long term contracts.- Realignment of financial incentives that focus on appropriate use and choice of medications, not driving utilization like the traditional PBM model.- CMM / MTM integration available.- and many more benefits that deliver unmatched value and restore integrity to pharmacy benefits.
